KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Other financing activities: 2009-2025

Historic Other financing activities for Tenet Healthcare (THC) over the last 17 years, with Q3 2025 value amounting to $71.0 million.

  • Tenet Healthcare's Other financing activities rose 10882.35% to $71.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.0 million, marking a year-over-year increase of 3947.37%. This contributed to the annual value of $33.0 million for FY2024, which is 5352.11% down from last year.
  • Latest data reveals that Tenet Healthcare reported Other financing activities of $71.0 million as of Q3 2025, which was up 10882.35% from -$16.0 million recorded in Q2 2025.
  • Tenet Healthcare's 5-year Other financing activities high stood at $71.0 million for Q3 2025, and its period low was -$102.0 million during Q1 2022.
  • Over the past 5 years, Tenet Healthcare's median Other financing activities value was $1.0 million (recorded in 2023), while the average stood at $526315.8.
  • As far as peak fluctuations go, Tenet Healthcare's Other financing activities surged by 330000.0% in 2024, and later plummeted by 70000.0% in 2025.
  • Over the past 5 years, Tenet Healthcare's Other financing activities (Quarter) stood at -$11.0 million in 2021, then skyrocketed by 127.27% to $3.0 million in 2022, then skyrocketed by 1733.33% to $55.0 million in 2023, then tumbled by 34.55% to $36.0 million in 2024, then skyrocketed by 97.22% to $71.0 million in 2025.
  • Its Other financing activities was $71.0 million in Q3 2025, compared to -$16.0 million in Q2 2025 and -$39.0 million in Q1 2025.